DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03651349 (ClinicalTrials.gov)	October 2020	26/8/2018	To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers	A Phase I Study to Determine the Maximum Tolerated Dose (MTD) of HK-001 and to Evaluate Its Pharmacokinetic Profile in Healthy Volunteers	Amyotrophic Lateral Sclerosis	Drug: HK-001;Drug: Placebo control	Everfront Biotech Co., Ltd.	NULL	Not yet recruiting	20 Years	N/A	All	56	Phase 1	Taiwan

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

October 2020

26/8/2018

To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers

A Phase I Study to Determine the Maximum Tolerated Dose (MTD) of HK-001 and to Evaluate Its Pharmacokinetic Profile in Healthy Volunteers

Amyotrophic Lateral Sclerosis

Drug: HK-001;Drug: Placebo control

Everfront Biotech Co., Ltd.

NULL

Not yet recruiting

20 Years

N/A

All

Phase 1

Taiwan